SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-005774
Filing Date
2024-04-25
Accepted
2024-04-25 16:16:04
Documents
73
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q knsa-20240331x10q.htm   iXBRL 10-Q 1902217
2 EX-10.1 knsa-20240331xex10d1.htm EX-10.1 74840
3 EX-10.2 knsa-20240331xex10d2.htm EX-10.2 77637
4 EX-31.1 knsa-20240331xex31d1.htm EX-31.1 11331
5 EX-31.2 knsa-20240331xex31d2.htm EX-31.2 10487
6 EX-32.1 knsa-20240331xex32d1.htm EX-32.1 6294
7 EX-32.2 knsa-20240331xex32d2.htm EX-32.2 6268
  Complete submission text file 0001558370-24-005774.txt   7657964

Data Files

Seq Description Document Type Size
8 EX-101.SCH knsa-20240331.xsd EX-101.SCH 51144
9 EX-101.CAL knsa-20240331_cal.xml EX-101.CAL 50141
10 EX-101.DEF knsa-20240331_def.xml EX-101.DEF 254357
11 EX-101.LAB knsa-20240331_lab.xml EX-101.LAB 442369
12 EX-101.PRE knsa-20240331_pre.xml EX-101.PRE 355660
77 EXTRACTED XBRL INSTANCE DOCUMENT knsa-20240331x10q_htm.xml XML 1177799
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11 7814399100
Kiniksa Pharmaceuticals, Ltd. (Filer) CIK: 0001730430 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38492 | Film No.: 24876530
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)